Maison Pommery & Associés : Financial Press Release

Maison Pommery & Associés reported H1 2026 consolidated revenue of €95.7m, down 12.4% reported vs. H1 2025 (€109.3m), though up 0.6% on a like-for-like basis. The decline was driven by the €9.6m impact from disposing of Heidsieck & Co Monopole and a €4.5m drag from reduced interprofessional sales, partially offset by Champagne revenue up 4.4% like-for-like (+7.1% for Champagne Pommery & Greno) and bottled volumes up 4.6% vs a 1.2% industry shipment gain. Management plans to maintain second-half momentum focused on premium cuvées while continuing refinancing discussions with banking partners; near-term outlook is described as in a still challenging market.

Analysis

The key signal is not headline sales; it is that the core brand is still taking share in a flat category while the weak parts of the portfolio are being de-emphasized. That is usually supportive for EBITDA quality, but only if premium mix offsets the loss of low-contribution volume and fixed costs stay contained. In other words, this is more a margin-bridge story than a top-line story, and the market should care more about gross margin and leverage than reported revenue.

The near-term catalyst is the refinancing process. That creates a binary setup over the next 1-3 months: a clean extension or strategic transaction would reduce the distress discount, while any sign of creditor pushback or due diligence slippage would likely overwhelm the modest operating progress. The U.S. weakness matters because it is the least forgiving geography for premium imports; if distributor inventories are elevated or the consumer trade-down persists, that becomes a 6-12 month drag on mix and price realization.

The contrarian view is that the market may be over-penalizing the reported decline while underestimating the value of share gains in Europe and premium cuvées. But the bigger risk is that investors extrapolate brand strength into equity upside before the balance sheet is resolved. If refinancing terms are dilutive or expensive, the operating improvement can be swallowed by higher interest expense, leaving equity value trapped even if the brand remains healthy.

Key Decisions for Investors

• Avoid initiating a fresh long in TBHC until refinancing visibility improves; treat this as a balance-sheet event first, operating story second. Falsify the cautious stance if the company secures an extension/reprice with no meaningful dilution and net leverage trends lower in the next update.
• If TBHC rallies on any refinancing headline, consider fading strength or adding a tactical short against the event-driven pop; the equity could re-rate lower if debt terms are punitive. Time horizon: 1-3 months, with downside most likely if due diligence or bank negotiations stall.
• Relative-value idea: long large-cap premium consumer/luxury exposure such as LVMH.PA versus short TBHC as a cleaner way to express premium-brand resilience without refinancing risk. This works best if market confidence in European premium consumption stays intact over the next quarter.
• Watch the U.S. channel closely before adding exposure: if the next disclosure shows continued North America weakness or inventory destocking, assume the premium mix story is not enough to offset operating deleverage. That would be a signal to stay sidelined for 6-12 months.
• If you already own TBHC, hedge event risk with a small downside hedge into the refinancing window rather than relying on fundamental upside; the stock’s skew is likely driven by capital-structure news, not gradual brand momentum.